ENTRADA THERAPEUTICS Trademark

Trademark Overview

On Thursday, May 7, 2020, a trademark application was filed for ENTRADA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ENTRADA THERAPEUTICS trademark a serial number of 88904724. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Entrada Therapeutics, Inc.. The ENTRADA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

House mark for a full line of pharmaceuticals, but not including pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis, all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer

Pharmaceutical research and development services
entrada therapeutics

General Information

Serial Number88904724
Word MarkENTRADA THERAPEUTICS
Filing DateThursday, May 7, 2020
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7422339
Registration DateTuesday, June 18, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements

Description of MarkThe mark consists of a design of five curved lines. The center of each line meets at the right side of the design, and the lines fan out to the left both above and below the center, forming an overall shape that resembles a curved arrow pointing to the right. The lines increase in width from left to right. To the right of the design is the stylized word "ENTRADA", with the stylized word "THERAPEUTICS" underneath.
Goods and ServicesHouse mark for a full line of pharmaceuticals, but not including pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis, all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe English translation of "ENTRADA" in the mark is "ENTRY".
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 21, 2020
Primary Code005
First Use Anywhere DateTuesday, June 14, 2022
First Use In Commerce DateTuesday, June 14, 2022
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 21, 2020
Primary Code042
First Use Anywhere DateTuesday, January 31, 2023
First Use In Commerce DateTuesday, January 31, 2023

Trademark Owner History

Party NameEntrada Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameEntrada Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameEntrada Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, May 11, 2020NEW APPLICATION ENTERED
Thursday, May 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 22, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 4, 2020ASSIGNED TO EXAMINER
Monday, August 10, 2020NON-FINAL ACTION WRITTEN
Monday, August 10, 2020NON-FINAL ACTION E-MAILED
Monday, August 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, February 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 27, 2021SOU EXTENSION 1 FILED
Wednesday, October 27, 2021SOU EXTENSION 1 GRANTED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 14, 2022SOU EXTENSION 2 FILED
Thursday, April 14, 2022SOU EXTENSION 2 GRANTED
Saturday, April 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 24, 2022SOU EXTENSION 3 FILED
Monday, October 24, 2022SOU EXTENSION 3 GRANTED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 18, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 18, 2023SOU EXTENSION 4 FILED
Tuesday, April 18, 2023SOU EXTENSION 4 GRANTED
Thursday, April 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023SOU EXTENSION 5 FILED
Monday, November 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 13, 2023SOU EXTENSION 5 GRANTED
Tuesday, November 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2024USE AMENDMENT FILED
Thursday, April 11, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, April 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, May 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics entrada sclerosis multiple pharmaceuticals related pharmaceutical excluding preparations treatment services development